OLYSIO Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

olysio

janssen-cilag (new zealand) ltd - simeprevir sodium 154.4mg equivalent to simeprevir 150.0 mg - capsule - 150 mg - active: simeprevir sodium 154.4mg equivalent to simeprevir 150.0 mg excipient: colloidal silicon dioxide croscarmellose sodium gelatin lactose monohydrate magnesium stearate opacode black s-1-277002 sodium laurilsulfate - olysio is indicated for the treatment of chronic hepatitis c (chc) genotype 1 or genotype 4 infection, in combination with other medicinal products for the treatment of chc infection.

GALEXOS CAPSULE Canada - anglais - Health Canada

galexos capsule

janssen inc - simeprevir (simeprevir sodium) - capsule - 150mg - simeprevir (simeprevir sodium) 150mg - hcv protease inhibitors

Olysio Union européenne - anglais - EMA (European Medicines Agency)

olysio

janssen-cilag international nv - simeprevir - hepatitis c, chronic - antivirals for systemic use - olysio is indicated in combination with other medicinal products for the treatment of chronic hepatitis c (chc) in adult patients.for hepatitis c virus (hcv) genotype specific activity.

Rosuvastatin Galenicum 10mg film-coated tablets Malte - anglais - Medicines Authority

rosuvastatin galenicum 10mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - rosuvastatin - film-coated tablet - rosuvastatin 10 mg - lipid modifying agents

Rosuvastatin Galenicum 20mg film-coated tablets Malte - anglais - Medicines Authority

rosuvastatin galenicum 20mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - rosuvastatin - film-coated tablet - rosuvastatin 20 mg - lipid modifying agents

Rosuvastatin Galenicum 40mg film-coated tablets Malte - anglais - Medicines Authority

rosuvastatin galenicum 40mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - rosuvastatin - film-coated tablet - rosuvastatin 40 mg - lipid modifying agents